PAULLA CHURCHWELL: Open Payments
NPI 1518450923 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 53 payments from 21 companies in 2025. Trend: 2023 $722 · 2024 $1,125 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $217 |
| Novo Nordisk Inc | 9 | $139 |
| ABBVIE INC. | 3 | $82 |
| Lilly USA, LLC | 3 | $47 |
| Corcept Therapeutics | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Exact Sciences Corporation | 2 | $34 |
| Amgen Inc. | 2 | $34 |
| Corium, LLC | 1 | $32 |
| Abbott Laboratories | 1 | $23 |
Products named: NURTEC ODT, Wegovy, Ozempic, QULIPTA, MOUNJARO, Korlym, Kerendia, ELIQUIS.
Industry payments across TX — which companies pay providers there.
